These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8924530)

  • 1. [Hyperthyroidism and hemodialysis].
    Martín Hernández T; Torres Cuadro A; Gijón Trigueros A; Lorenzo Carrero J
    An Med Interna; 1995 Aug; 12(8):391-2. PubMed ID: 8924530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful management of Graves' disease in a patient undergoing regular dialysis therapy.
    McKillop JH; Leung AC; Wilson R
    Arch Intern Med; 1985 Feb; 145(2):337-9. PubMed ID: 3838431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical hyperthyroidism in a patient receiving long-term hemodialysis.
    Soffer O; Chary KR; Hall WD
    Arch Intern Med; 1980 May; 140(5):708-9. PubMed ID: 7396599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with (131)I of toxic multinodular goiter. Assessment of a fixed dose protocol].
    Abós MD; Banzo J; Razola P; García F; Prats E
    Rev Esp Med Nucl; 2000 Jun; 19(3):182-6. PubMed ID: 11062080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and radioablation treatment of toxic multinodular goiter in a hemodialysis patient.
    Demko TM; Tulchinsky M; Miller KL; Cheung JY; Groff JA
    Am J Kidney Dis; 1998 Apr; 31(4):698-700. PubMed ID: 9531189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre.
    Tahrani AA; Rangan S; Moulik P
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):471-3. PubMed ID: 17647147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unmasking of thyrotoxicosis after initiation of regular haemodialysis treatment?
    Utas C; Yalçindağ C; Unlühizarci K; Doğukan A; Oymak O; Keleştimur F
    Nephrol Dial Transplant; 1998 Sep; 13(9):2423. PubMed ID: 9761549
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 131I therapy of toxic and non-toxic goiters.
    Beckers C
    Q J Nucl Med; 1999 Dec; 43(4):291-6. PubMed ID: 10731779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of Basedow disease after radioiodine therapy for nodular goiter].
    Cseke B; Balázs C
    Orv Hetil; 2003 Nov; 144(47):2327-9. PubMed ID: 14725052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-stage renal failure due to amyloidosis and recurrent fever on dialysis--is there a link?
    Piccoli GB; Soragna G; Palladini G; Magnano A; Sargiotto A; Picciotto G; Terzolo M
    Nephrol Dial Transplant; 2008 Jul; 23(7):2419-21. PubMed ID: 18587160
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The management of thyrotoxicosis: a schematic approach].
    Papi G; Carapezzi C; Corsello SM
    Minerva Endocrinol; 2002 Jun; 27(2):119-26. PubMed ID: 11961503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary infarction as a complication of thrombotic changes in an arteriovenous fistula of a patient with terminal renal insufficiency treated with long-term hemodialysis and recombinant human erythropoietin].
    Wanic-Kossowska M; Pietrzak I
    Pol Merkur Lekarski; 1996 Jul; 1(1):47-8. PubMed ID: 9156894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.